Protagonist Therapeutics
PTGX
#2241
Rank
A$12.36 B
Marketcap
A$189.46
Share price
2.00%
Change (1 day)
46.13%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2026 (TTM): A$1.69

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is A$1.82. In 2025 the company made an earnings per share (EPS) of A-$3.05 a decrease over its 2024 EPS that were of A$6.67.

EPS history for Protagonist Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.69-155.39%
2025A-$3.05-145.76%
2024A$6.67-402.7%
2023A-$2.21-43.08%
2022A-$3.87-3.7%
2021A-$4.0235%
2020A-$2.98-33.33%
2019A-$4.4774.42%
2018A-$2.56-20.74%
2017A-$3.23-45.64%
2016A-$5.95

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.01-210.66%๐Ÿ‡บ๐Ÿ‡ธ USA